The U.S. Food and Drug Administration said on Tuesday it was investigating cancer therapies made
by Gilead Sciences, Johnson & Johnson, Novartis
and others over the risk of hospitalizations and.
CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.
Expert said that manufacturing the T cells with a tyrosine kinase inhibitor may allow more patients to get allogeneic stem cell transplant, the current best means of long-term cure.
Baylor receives more than $5.8 million in CPRIT funding miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.